PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ATAI vs. CMPS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ATAI and CMPS is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

ATAI vs. CMPS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Atai Life Sciences N.V. (ATAI) and COMPASS Pathways plc (CMPS). The values are adjusted to include any dividend payments, if applicable.

-94.00%-92.00%-90.00%-88.00%-86.00%-84.00%-82.00%NovemberDecember2025FebruaryMarchApril
-92.44%
-91.39%
ATAI
CMPS

Key characteristics

Sharpe Ratio

ATAI:

-0.36

CMPS:

-0.92

Sortino Ratio

ATAI:

0.00

CMPS:

-1.48

Omega Ratio

ATAI:

1.00

CMPS:

0.82

Calmar Ratio

ATAI:

-0.33

CMPS:

-0.67

Martin Ratio

ATAI:

-0.90

CMPS:

-1.63

Ulcer Index

ATAI:

35.09%

CMPS:

39.54%

Daily Std Dev

ATAI:

88.72%

CMPS:

69.96%

Max Drawdown

ATAI:

-94.77%

CMPS:

-95.51%

Current Drawdown

ATAI:

-92.61%

CMPS:

-94.71%

Fundamentals

Market Cap

ATAI:

$291.51M

CMPS:

$290.07M

EPS

ATAI:

-$0.93

CMPS:

-$2.30

PS Ratio

ATAI:

946.46

CMPS:

0.00

PB Ratio

ATAI:

2.51

CMPS:

1.88

Total Revenue (TTM)

ATAI:

$308.00K

CMPS:

$0.00

Gross Profit (TTM)

ATAI:

$226.00K

CMPS:

-$63.07K

EBITDA (TTM)

ATAI:

-$120.28M

CMPS:

-$122.32M

Returns By Period

In the year-to-date period, ATAI achieves a 10.53% return, which is significantly higher than CMPS's -17.20% return.


ATAI

YTD

10.53%

1M

1.38%

6M

14.84%

1Y

-20.54%

5Y*

N/A

10Y*

N/A

CMPS

YTD

-17.20%

1M

0.97%

6M

-51.02%

1Y

-62.65%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ATAI vs. CMPS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATAI
The Risk-Adjusted Performance Rank of ATAI is 3636
Overall Rank
The Sharpe Ratio Rank of ATAI is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of ATAI is 4040
Sortino Ratio Rank
The Omega Ratio Rank of ATAI is 4040
Omega Ratio Rank
The Calmar Ratio Rank of ATAI is 3333
Calmar Ratio Rank
The Martin Ratio Rank of ATAI is 3434
Martin Ratio Rank

CMPS
The Risk-Adjusted Performance Rank of CMPS is 99
Overall Rank
The Sharpe Ratio Rank of CMPS is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of CMPS is 77
Sortino Ratio Rank
The Omega Ratio Rank of CMPS is 99
Omega Ratio Rank
The Calmar Ratio Rank of CMPS is 1212
Calmar Ratio Rank
The Martin Ratio Rank of CMPS is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ATAI vs. CMPS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and COMPASS Pathways plc (CMPS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ATAI, currently valued at -0.36, compared to the broader market-2.00-1.000.001.002.003.00
ATAI: -0.36
CMPS: -0.92
The chart of Sortino ratio for ATAI, currently valued at 0.00, compared to the broader market-6.00-4.00-2.000.002.004.00
ATAI: 0.00
CMPS: -1.48
The chart of Omega ratio for ATAI, currently valued at 1.00, compared to the broader market0.501.001.502.00
ATAI: 1.00
CMPS: 0.82
The chart of Calmar ratio for ATAI, currently valued at -0.33, compared to the broader market0.001.002.003.004.00
ATAI: -0.33
CMPS: -0.68
The chart of Martin ratio for ATAI, currently valued at -0.90, compared to the broader market-5.000.005.0010.0015.0020.00
ATAI: -0.90
CMPS: -1.63

The current ATAI Sharpe Ratio is -0.36, which is higher than the CMPS Sharpe Ratio of -0.92. The chart below compares the historical Sharpe Ratios of ATAI and CMPS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50NovemberDecember2025FebruaryMarchApril
-0.36
-0.92
ATAI
CMPS

Dividends

ATAI vs. CMPS - Dividend Comparison

Neither ATAI nor CMPS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ATAI vs. CMPS - Drawdown Comparison

The maximum ATAI drawdown since its inception was -94.77%, roughly equal to the maximum CMPS drawdown of -95.51%. Use the drawdown chart below to compare losses from any high point for ATAI and CMPS. For additional features, visit the drawdowns tool.


-94.00%-92.00%-90.00%-88.00%-86.00%NovemberDecember2025FebruaryMarchApril
-92.61%
-93.61%
ATAI
CMPS

Volatility

ATAI vs. CMPS - Volatility Comparison

Atai Life Sciences N.V. (ATAI) has a higher volatility of 33.43% compared to COMPASS Pathways plc (CMPS) at 21.88%. This indicates that ATAI's price experiences larger fluctuations and is considered to be riskier than CMPS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%40.00%45.00%NovemberDecember2025FebruaryMarchApril
33.43%
21.88%
ATAI
CMPS

Financials

ATAI vs. CMPS - Financials Comparison

This section allows you to compare key financial metrics between Atai Life Sciences N.V. and COMPASS Pathways plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab